ישראל -
עברית -
Ministry of Health
פרמיקסון 160 מג
padagis israel agencies ltd, israel - lipidosterolic extract of serenoa repens - קפסולות - lipidosterolic extract of serenoa repens 160 mg
ישראל -
עברית -
Ministry of Health
קיורוסורף
abic marketing ltd, israel - phospholipids fraction from porcine lung - תרחיף - phospholipids fraction from porcine lung 80 mg/ml - lung surfactants - treatment of preterm babies with respiratory distress syndrome (rds). prophylactic use in premature infants at high risk of rds.
ישראל -
עברית -
Ministry of Health
lipo-less - fat control formula
neopharm scientific ltd. - כלל האוכלוסיה - for general weight management and the prevention and treatment of obesity
ישראל -
עברית -
Ministry of Health
lipomatic liposuction device
emedix ltd. - רופא - מערכת לשאיבת שומן
ישראל -
עברית -
Ministry of Health
surgical instrumentation for liposuction
a.m.i. technologies, ltd. - מומחה - פלסטיקה-מכשיר לשאיבת שומן קונבנציונלית + מוצרים נלווים לשאיבה ) קנולות תעלות עבודה (
ישראל -
עברית -
Ministry of Health
apheresis machines, liposorbers, blood tubing line
בפקס בע"מ - מומחה - לשימוש במחלקות שונות כגון: אפרזיס, לפידים, בנק הדם, המטולוגיה
ישראל -
עברית -
Ministry of Health
breast implants, tissue expanders & accessories, liposuction & body contouring instruments and accessories
j-c healthcare ltd. - רופא - כירוגיה פלסטית
ישראל -
עברית -
Ministry of Health
אינפסורף
rafa laboratories ltd - calfactant as phospholipid - תרחיף - calfactant as phospholipid 35 mg/ml - lung surfactants - infasurf is indicated for the prevention of respiratory distress syndrome (rds) in premature infants at high risk for rds and for the treatment ("rescue") of premature infants who develop rds. infasurf decreases the incidence of rds mortality due to rds and air leaks associated with rds. prophylaxis : prophylaxis therapy at birth with infasurf is indicated for premature infants <29 weeks of gestational age at significant risk for rds. infasurf prophylaxis should be administered as soon as possible preferably within 30 minutes after birth. treatment: infasurf therapy is indicated for infants 72 hours of age with rds (confirmed by clinical and radiologic findings) and requiring endotracheal intubation.